Neutrophil Elastase as a Prognostic Biomarker and Driver of Tumor Progression in Diffuse Large B‐Cell Lymphoma

Xinyu Zheng, Lingling Wang, Ziqi Liu, Yunye Qiu, Jinbo Lu, Ling Shu, Chuanhai Xu, Meiling Zhou, Yuqing Miao, Yuexin Cheng · 2026

Read Neutrophil Elastase as a Prognostic Biomarker and Driver of Tumor Progression in Diffuse Large B‐Cell Lymphoma by Xinyu Zheng, Lingling Wang, Ziqi Liu, Yunye Qiu, Jinbo Lu, Ling Shu, Chuanhai Xu, Meiling Zhou, Yuqing Miao, Yuexin Cheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158270.txt.

Description

Xinyu Zheng and co-authors study an enzyme from white blood cells in a fast-growing lymphoma, in a paper published in 2026. The cancer, diffuse large B-cell lymphoma, varies widely in outcome, and neutrophil signals are gaining notice as clues. The enzyme, neutrophil elastase, can cut proteins around cells and may help tumors grow.

The team stained tumor tissue from eighty-seven patients treated at one hospital between 2020 and 2024. About half the tumors carried the enzyme. Those patients had worse risk scores, later stages, and faster cell growth markers, and they lived shorter lives with quicker relapse. In lab dishes, the enzyme sped lymphoma cell growth, and a blocker drug slowed it and raised cell death. The authors propose the enzyme as both a warning marker and a drug target.

Catalog record

CREATORXinyu Zheng, Lingling Wang, Ziqi Liu, Yunye Qiu, Jinbo Lu, Ling Shu, Chuanhai Xu, Meiling Zhou, Yuqing Miao, Yuexin Cheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13158270

Browse the full library · About the Tower of Babel